BOONE CAPITAL MANAGEMENT LLC
Q1 2025 Form 13-F

ATLANTA, GEORGIA
CIK 0001882053 · CRD 316230 · SEC-registered investment adviser
$293.8M Reported Value Total

BOONE CAPITAL MANAGEMENT LLC reports 3 total accounts under management (AUM). There are 3 discretionary accounts valued at $632,901,000, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
1 fund · $963.2M gross asset value
Hedge Fund: $963.2M
Source: Form ADV filed 2026-03-30
Reported value
$293.8M
Quarter over quarter
+2.6%
Holdings
12
Top-10 concentration
92.5%

Key People

Form ADV owners & control persons
Daniel Walter Boone
PRESIDENT AND CIO
Paul Edward Bottinelli
CCO, CFO, AND COO

Filing Navigation

13F Metrics

Loading 13F Metrics

Q1 2025 13F record

Q1 2025 13F filing summary

Q1 2025 Form 13F portfolio summary
Period of report March 31, 2025
Filed May 15, 2025
Form 13F-HR
Reported value $293.8M
Positions 12
Change in reported value -0.9%
New positions 3
Exited positions 4
Position turnover 43.8%
Top-10 concentration 92.5%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q2 2026 13F
Filed Aug 14, 2026
16 $427.5M
Q1 2026 13F
Filed May 15, 2026
13 $326.4M
Q4 2025 13F
Filed Feb 17, 2026
15 $318.6M
Q3 2025 13F
Filed Nov 14, 2025
16 $305.0M
Q2 2025 13F
Filed Aug 14, 2025
11 $233.2M
Q1 2025 13F
Filed May 15, 2025
12 $293.8M
Q4 2024 13F
Filed Feb 14, 2025
13 $296.5M
Q3 2024 13F
Filed Nov 14, 2024
17 $385.8M
Q2 2024 13F
Filed Aug 14, 2024
19 $383.4M
Q1 2024 13F
Filed May 15, 2024
21 $494.4M
Q4 2023 13F
Filed Feb 14, 2024
21 $428.4M
Q3 2023 13F
Filed Nov 14, 2023
13 $317.0M
Q2 2023 13F
Filed Aug 14, 2023
13 $278.6M
Q1 2023 13F
Filed May 15, 2023
12 $213.6M
Q4 2022 13F
Filed Feb 14, 2023
17 $194.9M

Top 12 holdings · Q1 2025

Largest Q1 2025 13F positions by reported value
# Holding Reported value % of portfolio
1 UNM UNUM GROUP $57.1M 19.42%
2 MDT MEDTRONIC PLC $35.4M 12.04%
3 MIRM MIRUM PHARMACEUTICALS INC $27.2M 9.25%
4 GMED GLOBUS MED INC $26.4M 8.99%
5 CI THE CIGNA GROUP $23.3M 7.93%
6 BMRN BIOMARIN PHARMACEUTICAL INC $23.1M 7.87%
7 MOH MOLINA HEALTHCARE INC $22.3M 7.57%
8 PRGO PERRIGO CO PLC $19.8M 6.73%
9 ISRG INTUITIVE SURGICAL INC $19.3M 6.56%
10 PNTG PENNANT GROUP INC $18.1M 6.16%
11 OFIX ORTHOFIX MED INC $15.5M 5.26%
12 BHVN BIOHAVEN LTD $6.5M 2.21%

Values as reported on the Q1 2025 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings